Yong-gao Mu

发表

Serum CCL2 and serum TNF-α--two new biomarkers predict bone invasion, post-treatment distant metastasis and poor overall survival in nasopharyngeal carcinoma.

C. Qian, Xiang Guo, Xing Lu, 2011, European journal of cancer.

Sensitization of Glioma Cells to Tamoxifen-Induced Apoptosis by Pl3-Kinase Inhibitor through the GSK-3β/β-Catenin Signaling Pathway

Chun Zhou, Peiqing Liu, Yong-gao Mu, 2011, PloS one.

Working memory and the identification of facial expression in patients with left frontal glioma.

C. Ke, Yong-gao Mu, Yu Jin, 2012, Neuro-oncology.

LABORATORY INVESTIGATION- HUMAN/ANIMAL TISSUE Clinical significance of vasculogenic mimicry in human gliomas

H. Ng, K. Sai, Yong-gao Mu, 2022 .

Activities of DNA-PK and Ku86, but not Ku70, may predict sensitivity to cisplatin in human gliomas

Yong-gao Mu, Jun Fu, Hong Shi, 2008, Journal of Neuro-Oncology.

Single nucleotide polymorphisms and expression of ERCC1 and ERCC2 vis-à-vis chemotherapy drug cytotoxicity in human glioma

Huayun Chen, K. Sai, Yong-gao Mu, 2007, Journal of Neuro-Oncology.

Real-world management and survival outcomes of patients with newly diagnosed gliomas from a single institution in China: A retrospective cohort study

Yinsheng Chen, Chengcheng Guo, K. Sai, 2019, Glioma.

MiR-181b sensitizes glioma cells to teniposide by targeting MDM2

Yanyang Sun, Yinsheng Chen, Chengcheng Guo, 2014, BMC Cancer.

[Nimotuzumab in combination with chemotherapy for patients with malignant gliomas].

K. Sai, Xiaobing Jiang, Xiang-heng Zhang, 2011, Zhonghua zhong liu za zhi [Chinese journal of oncology].

[Individualized chemotherapy based on drug sensitivity and resistance assay and MGMT protein expression for patients with malignant glioma--analysis of 42 cases].

K. Sai, Yong-gao Mu, Xiang-heng Zhang, 2006, Ai zheng = Aizheng = Chinese journal of cancer.

Clinical significance of vasculogenic mimicry in human gliomas

K. Sai, Qinghui Zhang, Yong-gao Mu, 2009 .